Multitude is presenting at the 15th World ADC conference in San Diego!
关于我们
Multitude Therapeutics (MTX) is a spinoff company created by Abmart to leverage its unparalleled target and antibody discovery capability for cancer immunotherapy. MTX focuses on developing novel antibody-drug conjugates (ADC), CAR-Ts and immuno-oncology antibodies for solid and hematological tumors. MTX’s therapeutic programs are based on novel cancer and immune cell surface targets discovered by monoclonal antibody arrays (Human Membrane Proteome MabArrayTM or HMP-MabArrayTM) powered by the exceptional antibody discovery capabilities built at Abmart.
- 网站
-
https://www.multitudetherapeutics.info
Multitude Therapeutics的外部链接
- 所属行业
- 生物技术研究
- 规模
- 11-50 人
- 总部
- Redwood City，California
- 类型
- 私人持股
- 创立
- 2018
- 领域
- MabArray platform based target discovery
地点
-
主要
获取路线
3698 Haven Ave
US，California，Redwood City，94063
Multitude Therapeutics员工
动态
-
Check out this exciting news! https://lnkd.in/gk_emqw7